Search Results - "Kartsonis, N. A."

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis by Kohno, S., Izumikawa, K., Yoshida, M., Takesue, Y., Oka, S., Kamei, K., Miyazaki, Y., Yoshinari, T., Kartsonis, N. A., Niki, Y.

“…The safety and efficacy profile of caspofungin and micafungin in Japanese patients with fungal infections were directly compared in this prospective,…”
Get full text

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation by Marty, Francisco M, Ljungman, Per, Chemaly, Roy F, Maertens, Johan, Dadwal, Sanjeet S, Duarte, Rafael F, Haider, Shariq, Ullmann, Andrew J, Katayama, Yuta, Brown, Janice, Mullane, Kathleen M, Boeckh, Michael, Blumberg, Emily A, Einsele, Hermann, Snydman, David R, Kanda, Yoshinobu, DiNubile, Mark J, Teal, Valerie L, Wan, Hong, Murata, Yoshihiko, Kartsonis, Nicholas A, Leavitt, Randi Y, Badshah, Cyrus

“…CMV infection is a common complication in patients undergoing hematopoietic-cell transplantation. The incidence of CMV infection was 23 percentage points lower…”
Get full text

Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infections by DiNubile, M. J., Strohmaier, K. M., Lupinacci, R. J., Meibohm, A. R., Sable, C. A., Kartsonis, N. A.

“…Invasive fungal infections (IFIs) are serious complications in elderly adults. Caspofungin may provide a useful therapeutic option for elderly patients with or…”
Get full text

Clinical monitoring of HIV-1 infection in the ERA of antiretroviral resistance testing by Kartsonis, N A, D'Aquila, R T

“…Viral replication of HIV-1 in the human body is a dynamic process. Incomplete suppression of replication during antiretroviral therapy ultimately selects for…”
Get more information

Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study by Kartsonis, Nicholas A., Saah, Alfred, Lipka, C. Joy, Taylor, Arlene, Sable, Carole A.

“…Objectives: To prospectively assess the efficacy and safety of caspofungin as second-line therapy for mucosal or invasive candidiasis in patients enrolled in…”
Get full text

Caspofungin: the first in a new class of antifungal agents by Kartsonis, Nicholas A, Nielsen, Jennifer, Douglas, Cameron M

“…Caspofungin is the first approved agent from a new class of antifungals, the echinocandins. By targeting the fungal cell wall (as opposed to the fungal cell…”
Get full text

Identification of RFamide neuropeptides in the medicinal leech by Evans, B D, Pohl, J, Kartsonis, N A, Calabrese, R L

“…Using a four-step reverse phase HPLC separation and RIA, five RFamide peptides were purified from CNS extracts of the leech Hirudo medicinalis. YMRFamide,…”
Get more information

Caspofungin in the Treatment of Symptomatic Candiduria by Sobel, Jack D., Bradshaw, Susan K., Lipka, C. Joy, Kartsonis, Nicholas A.

“…Background. Because the urine concentrations achieved by echinocandin antifungal agents are low, drugs from this class are excluded from consideration when…”
Get full text

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation by Ljungman, Per, Schmitt, Michael, Marty, Francisco M, Maertens, Johan, Chemaly, Roy F, Kartsonis, Nicholas A, Butterton, Joan R, Wan, Hong, Teal, Valerie L, Sarratt, Kendra, Murata, Yoshihiko, Leavitt, Randi Y, Badshah, Cyrus

“…Abstract Background In a phase 3 trial, letermovir reduced clinically significant cytomegalovirus infections (CS-CMVi) and all-cause mortality at week 24…”
Get full text

A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis by Betts, Robert F., Nucci, Marcio, Talwar, Deepak, Gareca, Marcelo, Queiroz-Telles, Flavio, Bedimo, Roger J., Herbrecht, Raoul, Ruiz-Palacios, Guillermo, Young, Jo-Anne H., Baddley, John W., Strohmaier, Kim M., Tucker, Kimberly A., Taylor, Arlene F., Kartsonis, Nicholas A.

“…Background. The standard caspofungin treatment regimen (50 mg/day after a 70-mg dose on day 1) is effective and well tolerated for the treatment of invasive…”
Get full text

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy by Maertens, Johan, Raad, Issam, Petrikkos, George, Boogaerts, Marc, Selleslag, Dominik, Petersen, Finn B., Sable, Carole A., Kartsonis, Nicholas A., Ngai, Angela, Taylor, Arlene, Patterson, Thomas F., Denning, David W., Walsh, Thomas J.

“…Background. Invasive aspergillosis (IA) is an important cause of morbidity and mortality among immunocompromised patients. Echinocandins are novel antifungal…”
Get full text

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents by WALSH, Thomas J, ADAMSON, Peter C, MILLER, Alisha, BRADSHAW, Susan K, LI, Susan X, SABLE, Carole A, KARTSONIS, Nicholas A, SEIBEL, Nita L, FLYNN, Patricia M, NEELY, Michael N, SCHWARTZ, Cindy, SHAD, Aziza, KAPLAN, Sheldon L, RODEN, Maureen M, STONE, Julie A

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis by Villanueva, Alvaro, Gotuzzo, Eduardo, Arathoon, Eduardo G, Noriega, L Miguel, Kartsonis, Nicholas A, Lupinacci, Robert J, Smietana, Juanita M, DiNubile, Mark J, Sable, Carole A

“…Candida esophagitis remains an important cause of morbidity in patients with advanced human immunodeficiency virus (HIV) infection. Fluconazole is widely…”
Get more information

Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study by Kartsonis, Nicholas A., Saah, Alfred J., Joy Lipka, C., Taylor, Arlene F., Sable, Carole A.

“…Objectives. The objective was to prospectively assess the efficacy and safety of caspofungin as salvage therapy for invasive aspergillosis in patients enrolled…”
Get full text

Letermovir (LET) for prevention of cytomegalovirus (CMV) infection: results from a phase III randomized, double-blind, placebo (PBO)-controlled trial in adult allogeneic hematopoietic cell transplant (alloHCT) recipients by Ljungman, P, Marty, FM, Chemaly, RF, Maertens, J, Duarte, RF, Teal, VL, Wan, H, Kartsonis, NA, Leavitt, RY, Badshah, C

Get full text

Invasive candidiasis in cancer patients: observations from a randomized clinical trial by DiNubile, Mark J., Hille, Darcy, Sable, Carole A., Kartsonis, Nicholas A.

“…Invasive candidiasis is a common and serious complication of cancer and its therapy. We retrospectively identified patients with malignancies enrolled in a…”
Get full text

Treatment of invasive candidiasis with caspofungin in the intensive care unit by DiNubile, MJ, Lupinacci, RJ, Sable, CA, Kartsonis, NA

Get full text